DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • France
  • /
  • Healthcare
Author Program NEWCreate Narrative
EMEIS logo

emeis Société anonyme Stock Price

ENXTPA:EMEIS Community·€2.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

EMEIS Share Price Performance

€0
-11.61 (-100.00%)
​
€15.50
Fair Value
€0
-11.61 (-100.00%)
​
Price €0
Fri, 26 Jun 26
Fair Value€15.50
Share Pricen/a

EMEIS Community Narratives

AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value €15.5 18.6% undervalued intrinsic discount

Staffing Pressures And Real Estate Risks Will Restrain Long Term Earnings Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value €16.53 23.7% undervalued intrinsic discount

Aging Demographics And Rising Occupancy Rates Will Support A Long-Term Recovery Narrative

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value €17.5 27.9% undervalued intrinsic discount

Aging Demographics And Higher Occupancy Will Drive A Strong Earnings Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
EMEIS logo
emeis Société anonyme
23.7% undervalued intrinsic discount

Aging Demographics And Rising Occupancy Rates Will Support A Long-Term Recovery Narrative

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 10 Jul
Read Narrative
EMEIS logo
emeis Société anonyme
18.6% undervalued intrinsic discount

Staffing Pressures And Real Estate Risks Will Restrain Long Term Earnings Recovery

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 26 Jun
Read Narrative
EMEIS logo
emeis Société anonyme
27.9% undervalued intrinsic discount

Aging Demographics And Higher Occupancy Will Drive A Strong Earnings Recovery

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Published 8 Dec 2025
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
EMEIS logo

EMEIS: Strengthened Governance And Stabilized Finances Will Support Future Re rating

Fair Value: €16.53 23.7% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
EMEIS logo

EMEIS: Stabilized Finances And New Governance Will Support Balanced Outlook

Fair Value: €15.5 18.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
EMEIS logo

Aging Demographics And Higher Occupancy Will Drive A Strong Earnings Recovery

Fair Value: €17.5 27.9% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Very undervalued with mediocre balance sheet.

1 Risk
4 Rewards
View Full Analysis

emeis Société anonyme Key Details

€6.0b

Revenue

€5.1b

Cost of Revenue

€875.2m

Gross Profit

€1.1b

Other Expenses

-€196.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-1.22
14.59%
-3.27%
192.3%
View Full Analysis

About EMEIS

Founded
1989
Employees
84600
CEO
Laurent Guillot
WebsiteView website
www.emeis.com

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, retirement homes, and psychiatric hospitals. Its services include concierge, housekeeping, ironing, internet connection, TV, telephone, free shuttles, catering and event organization, logistics support, DIY and gardening assistance, IT support, beauty and relaxation treatments, furniture on rent, fitness and wellness areas, and medical visits. The company’s post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, schizophrenic disorders, autism spectrum disorders, psychotraumatic disorders, neurodegenerative diseases, perinatal psychiatry, and burn-out. It serves patients in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the United Kingdom, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, China, and internationally. The company was founded in 1989 and is headquartered in Puteaux, France.

Recent EMEIS News & Updates

Recent updates

No updates

emeis Société anonyme Competitors

BIM logo

bioMérieux

Symbol: ENXTPA:BIM
Market cap: €8.4b
CLARI logo

Clariane

Symbol: ENXTPA:CLARI
Market cap: €1.4b
GDS logo

Ramsay Générale de Santé

Symbol: ENXTPA:GDS
Market cap: €1.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide